ProQR Therapeutics NV (NASDAQ:PRQR)

Delayed Data
As of 3:59pm ET
 -1.06 / -29.83%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 4.05, with a high estimate of 5.42 and a low estimate of 1.02. The median estimate represents a +61.81% increase from the last price of 2.51.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in ProQR Therapeutics NV. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 45.78%
Growthannually 2.12%


Growthquarterly 0.00%
Growthannually 1,544.04%
Key to the earnings and sales forecast charts.